A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay.

MLA

Grillberger, R., et al. “A Novel Flow-Based Assay Reveals Discrepancies in ADAMTS-13 Inhibitor Assessment as Compared with a Conventional Clinical Static Assay.” Journal of Thrombosis and Haemostasis : JTH, vol. 12, no. 9, Sept. 2014, pp. 1523–32. EBSCOhost, https://doi.org/10.1111/jth.12653.

APA

Grillberger, R., Gruber, B., Skalicky, S., Schrenk, G., Knöbl, P., Plaimauer, B., Turecek, P. L., Scheiflinger, F., & Rottensteiner, H. (2014). A novel flow-based assay reveals discrepancies in ADAMTS-13 inhibitor assessment as compared with a conventional clinical static assay. Journal of Thrombosis and Haemostasis : JTH, 12(9), 1523–1532. https://doi.org/10.1111/jth.12653

Chicago

Grillberger, R, B Gruber, S Skalicky, G Schrenk, P Knöbl, B Plaimauer, P L Turecek, F Scheiflinger, and H Rottensteiner. 2014. “A Novel Flow-Based Assay Reveals Discrepancies in ADAMTS-13 Inhibitor Assessment as Compared with a Conventional Clinical Static Assay.” Journal of Thrombosis and Haemostasis : JTH 12 (9): 1523–32. doi:10.1111/jth.12653.